Impact of the prognostic value of vascular invasion, but not lymphatic invasion, of the primary tumor in patients with breast cancer

Anticancer Research

Volumn 34, Issue 3, 2014, Pages 1255-1259

  Fujii, Takaaki ^a   Yajima, Reina ^a   Hirakata, Tomoko ^b   Miyamoto, Takeshi ^b   Fujisawa, Tomomi ^b   Tsutsumi, Soichi ^a   Ynagita, Yasuhiro ^b   Iijima, Misa ^b   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA PREFECTURAL CANCER CENTER   (Japan)

Author keywords

Breast cancer; Lymphatic invasion; Prognosis; Vascular invasion

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIMARY TUMOR; RADICAL RESECTION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SYSTEMIC DISEASE; BREAST TUMOR; CANCER STAGING; COMPARATIVE STUDY; FOLLOW UP; LYMPH NODE; LYMPH VESSEL; LYMPHATIC INVASION; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; TUMOR INVASION; TUMOR RECURRENCE; VASCULAR INVASION; VASCULARIZATION;

BREAST CANCER; LYMPHATIC INVASION; PROGNOSIS; VASCULAR INVASION;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84899675160     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rakha EA, Martin S, Morgan D, Pharoah PD, Hodi Z, Macmillan D and Elllis IO: The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer 118: 3670-3680, 2012.
2. Lauria R, Perrone F, Cariomagno C, De Laurentiis M, Morabito A, Gallo C, Varriale E, Pettinato G, Panico L and Petrella G: The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 76: 1772-1778, 1995.
3. Woo CS, Silberman H, Nakamura SK, Ye W, Sposto R, Colburn W, Waisman JR and Silverstein MJ: Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. Am J Surg 184: 337-340, 2002.
4. Song YJ, Shin SH, Cho JS, Park MH, Yoon JH and Jegal YJ: The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer. J Breast Cancer 14: 198-203, 2011.
5. Lee AK, DeLellis RA, Silverman ML, Heatley GJ and Wolfe HJ: Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 8: 1457-1465, 1990.
6. Sundquist M, Thorstenson S, Klintenberg C, Brudin L, Nordenskjold B: Indicators of locoregional recurrence in breast cancer. The South East Swedish Breast Cancer Group. Eur J Surg Oncol 26: 357-362, 2000.
7. Colleoni M, Rotmensz N, Maisonneuve P, Sonzogni A, Pruneri G, Casadio C, Luini A, Veronesi P, Intra M, Galimberti V, Torrisi R, Andrighetto S, Ghisini R, Goldhirsch A and Viale G: Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol 18: 1642-1640, 2007.
8. Lee AH, Pinder SE, Macmillan RD, Mitchell M, Ellis IO, Elston CW and Blamey RW: Prognostic value of lymphovascular invasion in women with lymph node-negative invasive breast carcinoma. Eur J Cancer 42: 357-362, 2006.
9. Davis BW, Gelber R, Goldhirsch A, Hartmann WH, Hollaway L, Russell I and Rudenstam CM: Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Hum Pathol 16: 1212-1218, 1985.
10. Ejlertsen B, Jensen MB, Rank F, Rasmussen BB, Christiansen P, Kroman N, Kvistgaard ME, Overgaard M, Toftdahl DB, Mouridsen HT, Danish Breast Cancer Cooperative Group: Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst 101: 729-735, 2009.
11. Achen MG and Stacker SA: Molecular control of lymphatic metastasis. Ann NY Acad Sci 1131: 225-234, 2009.
12. Royton D and Jackson DJ: Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol 217: 608-619, 2009.
13. Fujii T, Tabe Y, Yajima R, Yamaguchi S, Tsutsumi S, Asao T and Kuwano H: Process of distant lymph node metastasis in colorectal carcinoma of extracapsular invasion of lymph node mtastasis. BMC Cancer 11: 216, 2011.
14. Allred DC, Harvey JM, Berardo M and Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11: 155-168, 1998.
15. Shousha S: Oestrogen receptor status of breast carcinoma: Allred/H score conversion table. Histopathology 53: 346-347, 2008.
16. Cornwell LB, McMasters KM and Chagpar AB: The impact of lymphovascular invasion on lymph node status in patients with breast cancer. Am Surg 77: 874-877, 2011.
17. Braum M, Flucke U, Debad M, Walgenbach-Bruenagel G, Walgenbach KJ, Holler T, Polcher M, Wolfgarten M, Sauerwald A, Keyver-Paik M, Kuhr M, Buttner R and Kuhn W: Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): A clinically useful predictor for axillary lymph node metastases. Breast Cancer Res Treat 112: 503-511, 2008.
18. Fujii T, Yanagita Y, Fujisawa T, Hirakata T, Iijima M, Kuwano H: Implication of extracapsular invasion of sentinel lymph nodes in breast cancer: Prediction of non-sentinel lymph node metastasis. World J Surg 34: 544-548, 2010.
19. Yamaki S, Fujii T, Yajima R, Hirakata T, Yamaguchi S, Fujisawa T, Tsutusmi S, Asao T, Yanagita Y, Iijima M and Kuwano H: Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer. Surg Today 43: 901-905, 2013.